These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 33093777)

  • 21. Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjögren's syndrome.
    Kampolis CF; Fragkioudaki S; Mavragani CP; Zormpala A; Samakovli A; Moutsopoulos HM
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):94-101. PubMed ID: 29846161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and risk factors of interstitial lung disease in patients with primary Sjögren's syndrome: A systematic review and meta-analysis.
    He C; Chen Z; Liu S; Chen H; Zhang F
    Int J Rheum Dis; 2020 Aug; 23(8):1009-1018. PubMed ID: 32588976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interstitial lung disease in non-sicca onset primary Sjögren's syndrome: a large-scale case-control study.
    Gao H; Zou YD; Zhang XW; He J; Zhang J; Sun Y; Li ZG
    Int J Rheum Dis; 2018 Jul; 21(7):1423-1429. PubMed ID: 29968329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of patients with primary Sjögren's syndrome associated interstitial lung disease and relevant features of disease progression.
    Zhang T; Yuan F; Xu L; Sun W; Liu L; Xue J
    Clin Rheumatol; 2020 May; 39(5):1561-1568. PubMed ID: 31902032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease.
    Fischer A; Brown KK; Du Bois RM; Frankel SK; Cosgrove GP; Fernandez-Perez ER; Huie TJ; Krishnamoorthy M; Meehan RT; Olson AL; Solomon JJ; Swigris JJ
    J Rheumatol; 2013 May; 40(5):640-6. PubMed ID: 23457378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycophenolate and azathioprine efficacy in interstitial lung disease: a systematic review and meta-analysis.
    Lombardi F; Stewart I; Fabbri L; Adams W; Kawano-Dourado L; Ryerson CJ; Jenkins G;
    BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38413120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary manifestations of Sjögren's syndrome.
    Flament T; Bigot A; Chaigne B; Henique H; Diot E; Marchand-Adam S
    Eur Respir Rev; 2016 Jun; 25(140):110-23. PubMed ID: 27246587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for progression and prognosis of primary Sjögren's syndrome-associated interstitial lung disease in a Chinese population.
    Xu Y; Zhou J; Dong X; Guo X; Lu Y; Zheng Y
    Int J Rheum Dis; 2020 Dec; 23(12):1734-1740. PubMed ID: 33226736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiopoietin-like protein 2 as a novel marker for patients with primary Sjogren's syndrome-related interstitial lung disease.
    Shi L; Fu Q; Chen N; Liu R; Zheng Y
    Clin Exp Med; 2020 Aug; 20(3):393-399. PubMed ID: 32253547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycophenolate versus cyclophosphamide for progressive interstitial lung disease associated with systemic sclerosis: a 2-year case control study.
    Panopoulos ST; Bournia VK; Trakada G; Giavri I; Kostopoulos C; Sfikakis PP
    Lung; 2013 Oct; 191(5):483-9. PubMed ID: 23925736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glandular involvement in primary Sjögren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study.
    La Rocca G; Ferro F; Bulleri A; Fulvio G; Fonzetti S; Donati V; Romei C; Mosca M; Baldini C
    Clin Exp Rheumatol; 2022 Dec; 40(12):2344-2349. PubMed ID: 36533977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respiratory infection risk in primary Sjögren's syndrome complicated with interstitial lung disease: a retrospective study.
    Zhou X; Li H; Wang N; Jin Y; He J
    Clin Rheumatol; 2024 Feb; 43(2):707-715. PubMed ID: 38091126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and risk factors of interstitial pneumonia with autoimmune features.
    Vahidy S; Agyeman J; Zheng B; Donohoe K; Hambly N; Johannson KA; Assayag D; Fisher JH; Manganas H; Marcoux V; Khalil N; Kolb M; Ryerson CJ; ; Wong AW; Lok S; Morisset J; Fell CD; Shapera S; Gershon AS; Cox G; Halayko AJ; Sadatsafavi M; Wilcox PG; To T
    Respir Med; 2024 Jan; 221():107500. PubMed ID: 38142756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of cyclophosphamide on cytokines in patients with primary Sjögren's syndrome-associated interstitial lung disease].
    Mo HY; Wang LF; Xu J; Shi YH; Yang M; Zhou RH
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jul; 34(7):495-9. PubMed ID: 22041773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of disease-modifying antirheumatic drugs in primary Sjögren's syndrome-related interstitial lung disease.
    Erbasan F; Öğüt TS; Dilbil M; Nokay M; Terzioğlu ME; Yazısız V
    Med Clin (Barc); 2024 Nov; 163(10):490-495. PubMed ID: 39174415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary manifestations of Sjögren's syndrome.
    Shi JH; Liu HR; Xu WB; Feng RE; Zhang ZH; Tian XL; Zhu YJ
    Respiration; 2009; 78(4):377-86. PubMed ID: 19390161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sjögren's syndrome-associated interstitial lung disease: A multicenter study.
    Reina D; Roig Vilaseca D; Torrente-Segarra V; Cerdà D; Castellví I; Díaz Torné C; Moreno M; Narváez J; Ortiz V; Blavia R; Martín-Baranera M; Corominas H
    Reumatol Clin; 2016; 12(4):201-5. PubMed ID: 26573882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum bilirubin levels in primary Sjögren's syndrome: an association with interstitial lung disease.
    Peng YF; Lu FY; Ma LY
    BMC Pulm Med; 2023 Sep; 23(1):366. PubMed ID: 37777728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical course and risk factors for development and progression of interstitial lung disease in primary Sjögren's syndrome.
    Lee KA; Nam BD; Hwang JH; Kim HS
    Sci Rep; 2023 Jun; 13(1):9189. PubMed ID: 37280251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary Manifestations of Primary Sjögren's Syndrome: Underlying Immunological Mechanisms, Clinical Presentation, and Management.
    Gupta S; Ferrada MA; Hasni SA
    Front Immunol; 2019; 10():1327. PubMed ID: 31249572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.